Results 1 to 10 of about 112 (78)

CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions [PDF]

Acta Neuropathologica Communications
Erythroblastic sarcoma (ES) (previously called chloroma or granulocytic sarcoma) are rare hematological neoplams characterized by the proliferation of myeloid blasts at extramedullary sites, and primarily involve the skin and soft tissue of middle-aged ...
Arnault Tauziède-Espariat, Lucille Lew-Derivry, Samuel Abbou, Alice Métais, Gaëlle Pierron, Stéphanie Reynaud, Julien Masliah-Planchon, Cassandra Mariet, Lauren Hasty, Volodia Dangouloff-Ros, Nathalie Boddaert, Marie Csanyi, Aude Aline-Fardin, Claire Lamaison, Fabrice Chrétien, Kévin Beccaria, Stéphanie Puget, Pascale Varlet   +17 more
doaj   +2 more sources

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers. [PDF]

Adv Sci (Weinh), 2023
Pten and p53 are the most frequently mutated tumor suppressor genes in endometrial carcinomas. New technical approaches such as in vivo TAT‐Cre delivery, in vivo CRISPR/Cas9 editing, xenotransplantation or organoids unveiled pathological outcome of loss of Pten/p53 ablation.
Navaridas R, Vidal-Sabanés M, Ruiz-Mitjana A, Ruiz-Mitjana A, Altés G, Perramon-Güell A, Yeramian A, Egea J, Encinas M, Gatius S, Matias-Guiu X, Dolcet X.   +11 more
europepmc   +2 more sources

Análise de dados das campanhas de prevenção ao câncer da pele promovidas pela Sociedade Brasileira de Dermatologia de 1999 a 2005 Data analysis of the Brazilian Society of Dermatology skin cancer prevention campaign, 1999 to 2005

Anais Brasileiros de Dermatologia, 2006
FUNDAMENTOS: O câncer da pele é a neoplasia de maior incidência no Brasil, com 122.400 casos novos estimados para 2006, o que corresponde a 26% do total de neoplasias malignas. A exposição solar é o principal fator de risco conhecido.
doaj   +1 more source

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database. [PDF]

Sci Rep, 2022
Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E.   +13 more
europepmc   +1 more source

Neuroendocrine small cell carcinoma of the cervix: A case report. [PDF]

Mol Clin Oncol, 2021
Giordano G, D'Adda T, Pizzi S, Campanini N, Gambino G, Berretta R.   +5 more
europepmc   +1 more source

Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. [PDF]

Cancers (Basel), 2022
Renosi F, Callanan M, Lefebvre C.
europepmc   +1 more source

Expanding the spectrum of mesenchymal neoplasms with NR1D1-rearrangement. [PDF]

Genes Chromosomes Cancer, 2022
Lacambra MD, Antonescu CR, Chow C, Chiu WK, Demicco EG, Ferguson PC, Swanson D, To KF, Zhang L, Dickson BC.   +9 more
europepmc   +1 more source

Benign "lumps and bumps" of the vulva: A review. [PDF]

Int J Womens Dermatol, 2021
Sally R, Shaw KS, Pomeranz MK.
europepmc   +1 more source

EWSR1-The Most Common Rearranged Gene in Soft Tissue Lesions, Which Also Occurs in Different Bone Lesions: An Updated Review. [PDF]

Diagnostics (Basel), 2021
Flucke U, van Noesel MM, Siozopoulou V, Creytens D, Tops BBJ, van Gorp JM, Hiemcke-Jiwa LS.   +6 more
europepmc   +1 more source

Polycomb Directed Cell Fate Decisions in Development and Cancer. [PDF]

Epigenomes, 2022
German B, Ellis L.
europepmc   +1 more source